Oak Asset Management, LLC Gilead Sciences, Inc. Transaction History

Oak Asset Management, LLC

$282 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $494,360 - $564,687	8,303 New	8,303 $512,000
Q2 2022 Jul 15, 2022	SELL	$57.72 - $65.01 $580,028 - $653,285	-10,049 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$57.92 - $72.58 $2,896 - $3,629	-50 Reduced 0.5%	10,049 $597,000
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $446,114 - $506,348	-6,876 Reduced 40.51%	10,099 $733,000
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $19,697 - $21,251	-291 Reduced 1.69%	16,975 $1.12 Million
Q2 2021 Jul 14, 2021	SELL	$63.47 - $69.35 $4,442 - $4,854	-70 Reduced 0.4%	17,266 $1.19 Million
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $300 - $342	-5 Reduced 0.03%	17,336 $1.12 Million
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $42,147 - $48,025	-744 Reduced 4.11%	17,341 $1.01 Million
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $5,216 - $6,558	-84 Reduced 0.46%	18,085 $1.1 Million
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $868 - $1,008	-12 Reduced 0.07%	18,169 $1.4 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $12,338 - $15,803	-197 Reduced 1.07%	18,181 $1.36 Million
Q4 2019 Jan 09, 2020	SELL	$61.62 - $67.78 $56,998 - $62,696	-925 Reduced 4.79%	18,378 $1.19 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $2,937 - $3,243	47 Added 0.24%	19,303 $1.22 Million
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $30,254 - $33,926	489 Added 2.61%	19,256 $1.25 Million
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $19,196 - $21,505	-307 Reduced 1.61%	18,767 $1.22 Million
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $62,295 - $81,291	-1,029 Reduced 5.12%	19,074 $1.19 Million
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $8,197 - $9,075	-115 Reduced 0.57%	20,103 $1.55 Million
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $46,324 - $54,035	-714 Reduced 3.41%	20,218 $1.43 Million
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $3,787 - $4,617	-52 Reduced 0.25%	20,932 $1.58 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $1.49 Million - $1.75 Million	20,984	20,984 $1.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Asset Management, LLC with notifications on news.

Account